Cancer of unknown primary site: 20 questions to be answered
- PMID: 20943633
- DOI: 10.1093/annonc/mdq278
Cancer of unknown primary site: 20 questions to be answered
Abstract
Cancer of unknown primary (CUP) is a common, well-recognized and heterogeneous clinical syndrome. Patients with CUP present with metastatic disease in the absence of an identifiable primary tumour despite a diagnostic work-up. Aetiologically, CUP might either harbor primaries that cannot be detected by the standardized diagnostic investigations or carry distinct genetic and epigenetic aberrations. In this article we try to clarify the clinical and pathological enigma of CUP by answering 20 important questions related to this entity.
Similar articles
-
Liquid biopsy: a new diagnostic, predictive and prognostic window in cancers of unknown primary.Eur J Cancer. 2018 Dec;105:28-32. doi: 10.1016/j.ejca.2018.09.035. Epub 2018 Oct 30. Eur J Cancer. 2018. PMID: 30388661 Review.
-
[Cancer of unknown primary site origin--advances in diagnosis and therapy].Harefuah. 2008 Apr;147(4):294-8, 376, 375. Harefuah. 2008. PMID: 18686808 Hebrew.
-
Diagnostic Approaches to Neuroendocrine Neoplasms of Unknown Primary Site.Neuroendocrinology. 2020;110(7-8):563-573. doi: 10.1159/000504370. Epub 2019 Oct 28. Neuroendocrinology. 2020. PMID: 31658461 Review.
-
Diagnostic and therapeutic management of cancer of an unknown primary.Eur J Cancer. 2003 Sep;39(14):1990-2005. doi: 10.1016/s0959-8049(03)00547-1. Eur J Cancer. 2003. PMID: 12957453 Review.
-
Cancers of unknown primary.Br J Hosp Med (Lond). 2019 May 2;80(5):C70-C74. doi: 10.12968/hmed.2019.80.5.C70. Br J Hosp Med (Lond). 2019. PMID: 31059334 Review. No abstract available.
Cited by
-
Unfavorable cancers of unknown primaries: presentation and prognostic factors. A population-based 8-year experience.Med Oncol. 2013 Dec;30(4):706. doi: 10.1007/s12032-013-0706-5. Epub 2013 Sep 18. Med Oncol. 2013. PMID: 24045931
-
Differentiation of cancer cell origin and molecular subtype by plasma membrane N-glycan profiling.J Proteome Res. 2014 Feb 7;13(2):961-8. doi: 10.1021/pr400987f. Epub 2014 Jan 8. J Proteome Res. 2014. PMID: 24303873 Free PMC article.
-
Novel case of androgen receptor-positive cancer of unknown primary without serum prostate-specific antigen elevation that became progression free in the long term after primary combined androgen blockade.IJU Case Rep. 2020 Nov 30;4(1):59-63. doi: 10.1002/iju5.12241. eCollection 2021 Jan. IJU Case Rep. 2020. PMID: 33426501 Free PMC article.
-
Pan-cancer subtyping in a 2D-map shows substructures that are driven by specific combinations of molecular characteristics.Sci Rep. 2016 Apr 25;6:24949. doi: 10.1038/srep24949. Sci Rep. 2016. PMID: 27109935 Free PMC article.
-
Narrative review on serous primary peritoneal carcinoma of unknown primary site: four questions to be answered.Ann Transl Med. 2020 Dec;8(24):1709. doi: 10.21037/atm-20-941. Ann Transl Med. 2020. PMID: 33490221 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous